000 01112 a2200301 4500
005 20250515003529.0
264 0 _c20060126
008 200601s 0 0 eng d
022 _a0312-5963
024 7 _a10.2165/00003088-200544110-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Jonge, Milly E
245 0 0 _aClinical pharmacokinetics of cyclophosphamide.
_h[electronic resource]
260 _bClinical pharmacokinetics
_c2005
300 _a1135-64 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents, Alkylating
_xmetabolism
650 0 4 _aCyclophosphamide
_xmetabolism
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xmetabolism
700 1 _aHuitema, Alwin D R
700 1 _aRodenhuis, Sjoerd
700 1 _aBeijnen, Jos H
773 0 _tClinical pharmacokinetics
_gvol. 44
_gno. 11
_gp. 1135-64
856 4 0 _uhttps://doi.org/10.2165/00003088-200544110-00003
_zAvailable from publisher's website
999 _c15860175
_d15860175